Clinical Proteomics Centers for Infectious Diseases and Biodefense
What services does this resource provide?
The NIAID Clinical Proteomics Centers for Infectious Disease and Biodefense apply state-of-the-art proteomics technologies for the discovery, qualification, and verification of protein biomarkers in well-defined clinical samples collected for infectious diseases caused by NIAID Category A-C biodefense pathogens and emerging and re-emerging infectious diseases. At the conclusion of the verification phase of each project conducted by the NIAID Clinical Proteomics Centers (CPCs), scientists from the CPCs and their collaborators will be allowed 3 months to prepare and submit a manuscript for publication prior to putting the associated data in the public domain via the CPC websites and other public databases as appropriate. Candidate biomarkers will then be made available to the scientific community on the centers' websites, where they will be freely available to the public.
Reagents generated by the centers (e.g., clones, expression constructs, monoclonal antibodies, and polyclonal sera) will be distributed by the BEI Resources Repository.
Where are services provided?
Proteomic analyses on well-defined case versus control clinical samples will be performed by
Access
Related Resources and Information
